dc.contributor.advisor | Ul-Basher, Meer Sajed | |
dc.contributor.author | Islam, Md. Tariqul | |
dc.date.accessioned | 2024-08-22T05:51:10Z | |
dc.date.available | 2024-08-22T05:51:10Z | |
dc.date.copyright | 2021 | |
dc.date.issued | 2021-06 | |
dc.identifier.other | ID: 18264010 | |
dc.identifier.uri | http://hdl.handle.net/10361/23870 | |
dc.description | This internship report is submitted in partial fulfillment of the requirements for the degree of Masters of Business Administration, 2021. | en_US |
dc.description | Cataloged from the PDF version of the internship report. | |
dc.description | Includes bibliographical references (page 18). | |
dc.description.abstract | This research paper focuses on the discussion of the empirical proof of CAPM model on
pharmaceutical trade and concludes the speed of comeback of stock of CAPM models. The
capital quality valuation model is employed as tools for the comeback. The aim this paper is to
search out the speed of comeback of stock of pharmaceutical trade through capital quality
valuation model. To calculate the capital asset pricing I used 2 indexes from stock exchange,
DSEX and DS30.The Capital quality valuation Model (CAPM) provides a balanced linear
relationship between expected returns and quality risk. The aim of this study is to analyze the
risk-return relationship at intervals the CAPM framework. The survey checked out whether or
not CAPM may be a sensible indicator of Bangladesh's quality price. The amount 2019-2021 has
been thought-about for this. The searches at CAPM during this study well-tried that the variables
we have a tendency to took square measure still a great deal alive during this place with a major
correlation with stock returns. | en_US |
dc.description.statementofresponsibility | Md. Tariqul Islam | |
dc.format.extent | 36 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University internship reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Empirical evidence | en_US |
dc.subject | CAPM model | en_US |
dc.subject | Pharmaceutical industry | en_US |
dc.subject.lcsh | Capital assets pricing model. | |
dc.subject.lcsh | Capital investments. | |
dc.subject.lcsh | Pharmaceutical industry--Bangladesh. | |
dc.title | Empirical evidence of CAPM model at pharmaceutical industry of DSE | en_US |
dc.type | Internship report | en_US |
dc.contributor.department | Brac Business School, Brac University | |
dc.description.degree | M. Business Administration | |